)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Orthofix Medical
Orthofix Medical (OFIX) investor relations material
Orthofix Medical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary9 Nov, 2026
Executive summary
Q3 net sales were $207.9M, up 1.1% reported; pro forma sales grew 2.3% in constant currency. Limb Reconstruction and Therapeutic Solutions growth offset weaker Spine performance.
Net loss was $6.1M and adjusted EBITDA was $26.0M. Priorities include improving U.S. Spine execution, margins, working capital efficiency and free cash flow.
Financial highlights
Q3 reported net sales were $207.9M versus $205.6M a year earlier; adjusted EBITDA was $26.0M versus $24.6M.
GAAP operating income was $1.5M versus an operating loss of $17.0M; net loss narrowed to $6.1M from $22.8M, or $0.15 versus $0.57 loss per diluted share.
Nine-month net sales were $615.5M versus $602.4M; net loss narrowed to $42.8M from $90.0M.
Q3 gross profit was $146.5M, down 1.3%; GAAP gross margin was 70.5% versus 72.2% a year earlier.
Q3 SG&A fell $22.8M to $125.3M, mainly due to lower legal-related costs and commissions.
Outlook and guidance
FY2026 guidance was reduced to net sales of $825M–$830M from $845M–$855M and adjusted EBITDA of $86M–$88M from $95M–$98M; ranges assume current FX rates.
Sales outlook reflects Q3 results, Spine market softness and execution actions, international Limb Reconstruction order timing, and FX headwinds.
Q4 sequential growth is expected from seasonality and European distributor inventory purchases; most of the arrangement’s ~$15M 2026 sales benefit is expected in Q4.
Core revenue is expected to be positive in 2027 excluding MDR effects; European spine MDR requirements are expected to create a $22M 2027 net sales headwind from revenue-recognition timing.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Orthofix Medical
- Guidance raised on reimbursement restoration and innovation, with focus on organic growth.OFIX
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 net sales up 4–5% to $210.9M; guidance raised after Medicare reimbursement restored.OFIXQ2 2026
- Major product launches and commercial realignment position the company for sustainable growth.OFIXGoldman Sachs 47th Annual Global Healthcare Conference 2026
- Q1 2026 delivered steady growth and margin gains, supporting a strategy for sustained profitability.OFIXInvestor presentation
- Q1 2026 saw 3% pro forma sales growth, margin gains, and reaffirmed guidance with improved net loss.OFIXQ1 2026
- Annual meeting covers director elections, pay, auditor, and stock plan, with strong governance and ESG focus.OFIXProxy filing
- Shareholders to vote on board elections, executive pay, auditor ratification, and stock plan amendment.OFIXProxy filing
- Margin expansion and innovation pipeline position the business for sustained, profitable growth.OFIXTD Cowen 46th Annual Health Care Conference
- Growth momentum, channel optimization, and innovation set the stage for long-term value creation.OFIX2026 CG Musculoskeletal Conference
Next Orthofix Medical earnings date
Q4 202623 Feb, 2027
Orthofix Medical
Next Orthofix Medical earnings date
Q4 202623 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Orthofix Medical Inc designs, develops, and markets medical devices and biologics used in orthopedic and spine treatments. The company offers products for bone growth stimulation, spinal fusion, deformity correction, and fracture management. Orthofix serves healthcare providers and hospitals worldwide with surgical and non-surgical orthopedic solutions. The company is headquartered in Lewisville, Texas, and its shares are listed on the NASDAQ.